These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1402841)

  • 41. 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression).
    Keitner GI; Ryan CE; Miller IW; Kohn R; Epstein NB
    Am J Psychiatry; 1991 Mar; 148(3):345-50. PubMed ID: 1992837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An empirical study of the relationship between diagnosis and defense style.
    Bond MP; Vaillant JS
    Arch Gen Psychiatry; 1986 Mar; 43(3):285-8. PubMed ID: 3954550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.
    Casacalenda N; Perry JC; Looper K
    Am J Psychiatry; 2002 Aug; 159(8):1354-60. PubMed ID: 12153828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery and major depression: factors associated with twelve-month outcome.
    Keitner GI; Ryan CE; Miller IW; Norman WH
    Am J Psychiatry; 1992 Jan; 149(1):93-9. PubMed ID: 1728193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
    Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
    Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The determination of defense style by questionnaire.
    Andrews G; Pollock C; Stewart G
    Arch Gen Psychiatry; 1989 May; 46(5):455-60. PubMed ID: 2785372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the best sequential treatment strategy in the treatment of depression? Adding pharmacotherapy to psychotherapy or vice versa?
    Dekker J; Van HL; Hendriksen M; Koelen J; Schoevers RA; Kool S; van Aalst G; Peen J
    Psychother Psychosom; 2013; 82(2):89-98. PubMed ID: 23295630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic depression.
    Howland RH
    Hosp Community Psychiatry; 1993 Jul; 44(7):633-9. PubMed ID: 8354502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.
    Brown C; Schulberg HC; Madonia MJ; Shear MK; Houck PR
    Am J Psychiatry; 1996 Oct; 153(10):1293-300. PubMed ID: 8831437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelations between ego functions and personality traits: their relation to psychotherapy outcome.
    Conte HR; Plutchik R; Buck L; Picard S; Karasu TB
    Am J Psychother; 1991 Jan; 45(1):69-77. PubMed ID: 2018198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy].
    Kool S; Schoevers R; Duijsens IJ; Peen J; van Aalst G; de Jonghe F; Dekker J
    Tijdschr Psychiatr; 2007; 49(6):361-72. PubMed ID: 17611937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immature defense mechanisms predict poor response to psychotherapy in major depressive patients with comorbid cluster B personality disorder.
    Scaini CR; Vieira IS; Machado R; de Azevedo Cardoso T; Mondin T; Souza L; Molina ML; Jansen K; da Silva RA
    Braz J Psychiatry; 2022 Nov; 44(5):469-477. PubMed ID: 35896153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychotherapy alone and combined with pharmacotherapy in the treatment of depression.
    de Jonghe F; Hendricksen M; van Aalst G; Kool S; Peen V; Van R; van den Eijnden E; Dekker J
    Br J Psychiatry; 2004 Jul; 185():37-45. PubMed ID: 15231554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical utility of the Defensive Functioning Scale in the assessment of depression.
    DeFife JA; Hilsenroth MJ
    J Nerv Ment Dis; 2005 Mar; 193(3):176-82. PubMed ID: 15729107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of long-term psychodynamic psychotherapy in improving attachment patterns, defense styles, and alexithymia in patients with depressive/anxiety disorders.
    Khademi M; Hajiahmadi M; Faramarzi M
    Trends Psychiatry Psychother; 2019; 41(1):43-50. PubMed ID: 30994785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-rated defense style, life stress, and health status: an empirical assessment.
    Flannery RB; Perry JC
    Psychosomatics; 1990; 31(3):313-20. PubMed ID: 2388985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defense style changes with the addition of psychodynamic group therapy to clonazepam in social anxiety disorder.
    Knijnik DZ; Salum GA; Blanco C; Moraes C; Hauck S; Mombach CK; Strapasson AC; Manfro GG; Eizirik CL
    J Nerv Ment Dis; 2009 Jul; 197(7):547-51. PubMed ID: 19597364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specificities of defense mechanisms in bipolar affective disorder: relations with symptoms and therapeutic alliance.
    Kramer U; de Roten Y; Perry JC; Despland JN
    J Nerv Ment Dis; 2009 Sep; 197(9):675-81. PubMed ID: 19752647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychometric properties of the defense style questionnaire (DSQ-40) in adolescents.
    Ruuttu T; Pelkonen M; Holi M; Karlsson L; Kiviruusu O; Heilä H; Tuisku V; Tuulio-Henriksson A; Marttunen M
    J Nerv Ment Dis; 2006 Feb; 194(2):98-105. PubMed ID: 16477187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.